Overview: Smart wearables track health changes daily and help spot early warning signs before problems grow ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

DexCom will release its fourth-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...

In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...

Shares rose 6.4% to $71.73, putting the stock on pace for its highest close since September, according to Dow Jones Market ...

This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.

Medical advances transform care while industry tackles sustainability challenges and skilled worker shortages.

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

James Hume and Cormac Izuchukwu are set to feature in Ulster's United Rugby Championship game against Connacht at on Saturday ...